LifeMD, Inc. - Common Stock (LFMD)
8.2000
+2.1000 (34.43%)
NASDAQ · Last Trade: Apr 29th, 1:56 PM EDT
Detailed Quote
Previous Close | 6.100 |
---|---|
Open | 8.030 |
Bid | 8.200 |
Ask | 8.230 |
Day's Range | 7.020 - 8.420 |
52 Week Range | 3.990 - 12.88 |
Volume | 15,720,266 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 663,670 |
Chart
About LifeMD, Inc. - Common Stock (LFMD)
Lifemd Inc is a biotechnology company focused on advancing personalized medicine by leveraging cutting-edge technology and data analytics to develop innovative diagnostic solutions and therapeutics. Their mission centers around improving patient outcomes through tailored healthcare approaches, harnessing the power of genetic information and biomarkers to better understand individual health traits and disease predispositions. By aiming to provide precise treatment options, Lifemd Inc is dedicated to transforming the landscape of healthcare and empowering patients with actionable insights for managing their health. Read More
News & Press Releases
Via Benzinga · April 29, 2025
Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · April 29, 2025
LifeMD shares are trading higher Tuesday after the company announced it will offer access to Wegovy.
Via Benzinga · April 29, 2025
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · April 29, 2025
Patients will be able to access Novo Nordisk’s direct-to-patient online pharmacy, NovoCare, through the telehealth providers.
Via Stocktwits · April 29, 2025
Via Benzinga · April 29, 2025
The deal allows Hims & Hers to sell Eli Lilly's Zepbound on its telehealth platform.
Via Investor's Business Daily · April 1, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · March 11, 2025
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · March 11, 2025

After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · March 10, 2025

Via Benzinga · March 11, 2025

U.S. stock futures rose on Tuesday following Monday's heavy selloff. Futures of all four benchmark indices surged in premarket trading.
Via Benzinga · March 11, 2025

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir Technologies, Inc.
Via Benzinga · March 10, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Via Chartmill · February 21, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · February 21, 2025

Virtual healthcare provider Teladoc Health Inc. (NYSE: TDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023
Via MarketBeat · July 24, 2024

Telehealth stocks are on the rise as firms expand virtual healthcare services, boosting patient outcomes and engagement.
Via InvestorPlace · July 16, 2024

Via Benzinga · June 10, 2024

Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments
Via MarketBeat · June 3, 2024

LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result
Via MarketBeat · May 28, 2024

Via Benzinga · May 9, 2024

Via Benzinga · May 9, 2024

LFMD stock results show that LifeMD beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 8, 2024